Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) EV/FCF Ratio: 24.87x

Is Bio-Rad Laboratories, Inc.’s EV/FCF ratio high or low?

Bio-Rad Laboratories, Inc.'s EV/FCF ratio of 24.87x is 51% below its 5-year average of 51.13x, near the low end of its 5-year range (20.68x–198.52x).

The EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO) is 24.87x as of Tuesday, June 9, 2026. It is below its 12-month average by 0.58% (25.01x).

BIO EV/FCF Ratio Chart

BIO EV/FCF Ratio
25.44x+20.45% 1Y
Zoom

BIO Average EV/FCF Ratio Chart

BIO Current vs Average EV/FCF Ratio Chart

BIO EV/FCF Ratio Metrics

EV/FCF RATIO

24.87x

EV/FCF RATIO AVG TTM

25.01x

EV/FCF RATIO AVG 3Y

43.94x

EV/FCF RATIO AVG 5Y

51.13x

EV/FCF RATIO AVG 10Y

112.67x

EV/FCF RATIO AVG 15Y

87.02x

EV/FCF RATIO AVG 20Y

75.24x

CURRENT VS TTM AVG

-0.58%

CURRENT VS 3Y AVG

-43.39%

CURRENT VS 5Y AVG

-51.36%

CURRENT VS 10Y AVG

-77.93%

CURRENT VS 15Y AVG

-71.42%

CURRENT VS 20Y AVG

-66.94%

BIO Competitors' EV/FCF Ratio

NAMEMARKET CAPEV/FCF RATIOTTM3Y5Y
Bio-Rad Laboratories, Inc. (BIO)24.87x25.01x43.94x51.13x
Charles River Laboratories International, Inc. (CRL)$9.14B31.07x21.19x29.11x35.24x
Hims & Hers Health, Inc. (HIMS)$6.46B99.26x82.84x71.51x71.51x
Align Technology, Inc. (ALGN)$12.76B17.17x17.74x29.63x39.00x
Hologic, Inc. (HOLX)$16.97B17.53x16.89x18.61x15.13x
Moderna, Inc. (MRNA)$18.94B27.77x20.23x39.97x29.53x
BioNTech SE (BNTX)$21.87B9.68x18.15x9.84x13.27x
Mettler-Toledo International Inc. (MTD)$23.50B32.45x33.77x33.52x38.39x
Waters Corporation (WAT)$24.19B134.83x42.98x42.91x41.35x
Veeva Systems Inc. (VEEV)$27.37B50.23x29.28x32.90x38.29x

Cash Flow Valuation Comparison

EV/FCF

24.9x

P/FCF

22.4x

FCF Yield

4.46%

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

  • EV/FCF accounts for debt and cash through enterprise value
  • P/FCF only considers equity value
  • EV/FCF can be compared across companies with different debt levels
  • Both measure how the market values cash generation

Bio-Rad Laboratories, Inc. EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. EV/FCF Ratio FAQ

What is the EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The EV/FCF ratio for BIO stock is 24.87x.
Is Bio-Rad Laboratories, Inc.'s EV/FCF ratio high or low?
Bio-Rad Laboratories, Inc.'s EV/FCF ratio of 24.87x is 51% below its 5-year average of 51.13x, near the low end of its 5-year range (20.68x–198.52x).
What is the TTM average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average EV/FCF ratio for BIO stock is 25.01x.
What is the 3Y average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average EV/FCF ratio for BIO stock is 43.94x.
What is the 5Y average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average EV/FCF ratio for BIO stock is 51.13x.
What is the 10Y average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average EV/FCF ratio for BIO stock is 112.67x.
What is the 15Y average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average EV/FCF ratio for BIO stock is 87.02x.
What is the 20Y average EV/FCF ratio for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average EV/FCF ratio for BIO stock is 75.24x.

Bio-Rad Laboratories, Inc. EV/FCF Ratio History

DATEEV/FCF RATIO
2026-06-0325.44x
2026-06-0225.54x
2026-06-0125.49x
2026-05-2926.02x
2026-05-2826.45x
2026-05-2725.48x
2026-05-2624.85x
2026-05-2224.15x
2026-05-2124.08x
2026-05-2024.16x
2026-05-1923.65x
2026-05-1823.71x
2026-05-1521.12x
2026-05-1421.02x
2026-05-1320.82x
2026-05-1220.68x
2026-05-1120.84x
2026-05-0821.63x
2026-05-0721.86x
2026-05-0621.99x
2026-05-0521.84x
2026-05-0421.90x
2026-05-0121.80x
2026-04-3023.58x
2026-04-2922.51x
2026-04-2822.81x
2026-04-2723.38x
2026-04-2423.42x
2026-04-2322.96x
2026-04-2224.36x
2026-04-2124.71x
2026-04-2024.54x
2026-04-1724.23x
2026-04-1623.66x
2026-04-1524.01x
2026-04-1423.74x
2026-04-1323.45x
2026-04-1022.80x
2026-04-0922.68x
2026-04-0822.94x
2026-04-0722.71x
2026-04-0622.77x
2026-04-0222.86x
2026-04-0122.74x
2026-03-3122.77x
2026-03-3022.16x
2026-03-2721.81x
2026-03-2622.61x
2026-03-2522.40x
2026-03-2422.29x
2026-03-2321.78x
2026-03-2021.74x
2026-03-1921.78x
2026-03-1821.99x
2026-03-1722.10x
2026-03-1621.51x
2026-03-1321.62x
2026-03-1221.55x
2026-03-1122.13x
2026-03-1021.98x
2026-03-0922.24x
2026-03-0622.13x
2026-03-0522.79x
2026-03-0423.20x
2026-03-0322.87x
2026-03-0222.83x
2026-02-2722.75x
2026-02-2622.51x
2026-02-2522.11x
2026-02-2422.04x
2026-02-2322.01x
2026-02-2022.23x
2026-02-1922.27x
2026-02-1822.19x
2026-02-1721.77x
2026-02-1321.17x
2026-02-1223.75x
2026-02-1126.44x
2026-02-1026.94x
2026-02-0926.54x
2026-02-0627.07x
2026-02-0526.91x
2026-02-0427.42x
2026-02-0326.87x
2026-02-0226.74x
2026-01-3026.44x
2026-01-2926.54x
2026-01-2826.93x
2026-01-2726.76x
2026-01-2626.89x
2026-01-2326.67x
2026-01-2227.36x
2026-01-2127.87x
2026-01-2027.97x
2026-01-1628.03x
2026-01-1528.71x
2026-01-1428.41x
2026-01-1328.72x
2026-01-1228.79x
2026-01-0928.85x
2026-01-0828.47x
2026-01-0728.87x
2026-01-0628.99x
2026-01-0528.73x
2026-01-0227.37x
2025-12-3127.19x
2025-12-3027.31x
2025-12-2927.25x
2025-12-2627.26x
2025-12-2427.09x
2025-12-2327.03x
2025-12-2227.33x
2025-12-1927.07x
2025-12-1826.94x
2025-12-1727.05x
2025-12-1627.11x
2025-12-1527.58x
2025-12-1227.60x
2025-12-1128.06x
2025-12-1028.15x
2025-12-0927.59x
2025-12-0827.63x
2025-12-0528.36x
2025-12-0428.55x
2025-12-0328.57x
2025-12-0228.43x
2025-12-0128.67x
2025-11-2828.93x
2025-11-2629.11x
2025-11-2529.52x
2025-11-2428.74x
2025-11-2128.28x
2025-11-2027.24x
2025-11-1927.33x
2025-11-1827.57x
2025-11-1727.27x
2025-11-1428.00x
2025-11-1328.30x
2025-11-1229.13x
2025-11-1128.01x
2025-11-1027.54x
2025-11-0727.39x
2025-11-0627.47x
2025-11-0527.75x
2025-11-0427.82x
2025-11-0327.86x
2025-10-3128.51x
2025-10-3027.32x
2025-10-2928.50x
2025-10-2828.87x
2025-10-2729.32x
2025-10-2429.60x
2025-10-2329.52x
2025-10-2229.15x
2025-10-2128.94x
2025-10-2028.21x
2025-10-1727.27x
2025-10-1627.46x
2025-10-1526.95x
2025-10-1426.89x
2025-10-1326.78x
2025-10-1026.31x
2025-10-0926.54x
2025-10-0826.71x
2025-10-0726.22x
2025-10-0627.21x
2025-10-0326.92x
2025-10-0226.04x
2025-10-0126.33x
2025-09-3024.95x
2025-09-2924.15x
2025-09-2624.25x
2025-09-2524.17x
2025-09-2424.66x
2025-09-2325.08x
2025-09-2225.19x
2025-09-1925.24x
2025-09-1825.43x
2025-09-1724.95x
2025-09-1625.10x
2025-09-1524.94x
2025-09-1224.95x
2025-09-1125.38x
2025-09-1024.68x
2025-09-0925.39x
2025-09-0825.74x
2025-09-0526.13x
2025-09-0425.66x
2025-09-0325.55x
2025-09-0225.76x
2025-08-2926.32x
2025-08-2825.99x
2025-08-2725.93x
2025-08-2626.22x
2025-08-2526.28x
2025-08-2226.79x
2025-08-2125.32x
2025-08-2025.56x
2025-08-1925.58x
2025-08-1825.29x
2025-08-1525.37x
2025-08-1425.49x
2025-08-1325.48x
2025-08-1224.51x
2025-08-1123.71x
2025-08-0823.69x
2025-08-0723.77x
2025-08-0623.69x
2025-08-0524.31x
2025-08-0424.67x
2025-08-0125.28x
2025-07-3121.94x
2025-07-3023.61x
2025-07-2923.82x
2025-07-2823.87x
2025-07-2524.79x
2025-07-2424.61x
2025-07-2324.19x
2025-07-2223.22x
2025-07-2123.11x
2025-07-1823.30x
2025-07-1723.57x
2025-07-1623.37x
2025-07-1523.38x
2025-07-1423.67x
2025-07-1124.19x
2025-07-1024.43x
2025-07-0923.86x
2025-07-0823.66x
2025-07-0723.35x
2025-07-0323.73x
2025-07-0223.65x
2025-07-0123.43x
2025-06-3022.87x
2025-06-2723.09x
2025-06-2623.05x
2025-06-2522.84x
2025-06-2422.58x
2025-06-2322.38x
2025-06-2022.48x
2025-06-1822.08x
2025-06-1721.95x
2025-06-1622.06x
2025-06-1321.66x
2025-06-1222.12x
2025-06-1121.93x
2025-06-1021.96x
2025-06-0921.54x
2025-06-0621.02x
2025-06-0521.02x
2025-06-0421.25x
2025-06-0321.12x
2025-06-0220.78x
2025-05-3021.66x
2025-05-2921.71x
2025-05-2821.84x
2025-05-2721.95x
2025-05-2321.39x
2025-05-2221.67x
2025-05-2121.75x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz